ZBISF - Cronos: A Look At The Competition In Biosynthesis

Earlier this year I discussed why I am bearish overall on Cronos Group Inc (CRON), but I did note the company's partnership with Ginkgo Bioworks was a key part of the bull thesis. That partnership sees Ginkgo attempting produce cannabinoids via biosynthesis using yeast, rather than by growing cannabis, which has the potential to greatly reduce the cost of producing cannabinoids and allow the production of minor cannabinoids in large quantities. However CRON isn't the only company interested in producing cannabinoids via biosynthesis. As such, those taking a position in CRON will need